Skip to main content

Security report for centrofarmacovigilanzabolzano.it

Centro di Farmacovigilanza della Provincia Autonoma di Bolzano · Healthcare · Italy

Medium risk. 8 critical or high findings in GDPR outside view, Email security and 2 other checks.

Security score

60/100

Risk levelMedium

0–100, higher is better. How it is calculated

The Centro di Farmacovigilanza della Provincia Autonoma di Bolzano operates as a regional pharmacovigilance center focused on the surveillance, evaluation, and prevention of adverse drug and vaccine reactions. It collaborates closely with national and regional health authorities, including AIFA and the Regione Veneto, and is hosted by the University of Verona. The website serves healthcare professionals and the public by providing information, coordination, and training related to drug safety. Technically, the website uses a modern Bootstrap framework with responsive design and standard web technologies. It loads external CSS and icon libraries from trusted CDNs, ensuring a consistent user experience across devices. However, no CMS or advanced platform is detected, and performance is moderate. SEO and accessibility are basic but adequate for the site's purpose. From a security perspective, the site uses HTTPS but lacks advanced security headers and cookie consent mechanisms, which are important for compliance with privacy regulations such as GDPR. No forms collecting sensitive data are present, reducing immediate risk. WHOIS data confirms domain legitimacy and consistency with the business timeline. No WAF or blocking mechanisms interfere with access. Overall, the site is trustworthy and professionally maintained but could improve privacy compliance and security posture by implementing cookie consent, security headers, and publishing security policies.

Scanned

NIS2 and GDPR posture

GDPR outside view
28/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

  2. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching centrofarmacovigilanzabolzano.it

This scan found 27 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
25
Email security
75
DNS health
60
Network security
100
GDPR outside view
28
Average
60

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention centrofarmacovigilanzabolzano.it, from OffSeq Breach.

No leaked records found

Breach holds no records for centrofarmacovigilanzabolzano.it right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website represents a small but important public health entity specializing in pharmacovigilance within the Italian healthcare sector. Its market position is regional with strong ties to national agencies and academic institutions. The business model is service-oriented, focusing on regulatory compliance, data collection, and public information dissemination. The target audience includes healthcare providers, regional health authorities, and citizens concerned with drug safety. The partnership with the University of Verona and Regione Veneto enhances credibility and operational capacity. Growth potential lies in expanding training projects and digital reporting tools.

Security posture

The current security maturity is moderate. The site benefits from HTTPS encryption and limited attack surface due to absence of data collection forms. However, the lack of security headers and cookie consent mechanisms indicates gaps in defense-in-depth and privacy compliance. No incident response or security policy is published, which may hinder rapid response to security events. No known vulnerabilities or exposed sensitive data were detected. The security posture would benefit from adopting standard HTTP security headers, implementing GDPR-compliant cookie banners, and publishing incident response contacts.

Recommendations

  1. Implement a cookie consent mechanism to comply with GDPR and enhance user privacy transparency.
  2. Add HTTP security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security to improve protection against common web attacks.
  3. Publish a clear security policy and incident response contact information on the website to improve transparency and readiness.
  4. Enable DNSSEC for the domain to strengthen DNS security and prevent spoofing.
  5. Regularly audit and update third-party libraries and dependencies to mitigate potential vulnerabilities.

Contact details published on the site

Addresses
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Centro di Farmacovigilanza della Provincia Autonoma di Bolzano
Description
Il Centro Regionale di Farmacovigilanza della Provincia Autonoma di Bolzano si occupa delle attività di sorveglianza dei medicinali e svolge attività di coordinamento nella raccolta, gestione e valutazione periodica delle schede di segnalazione di reazione avversa. Opera in collaborazione con l'AIFA e la Regione Veneto, ed è collocato presso il Dipartimento di Diagnostica e Sanità pubblica dell’Università di Verona.
Key services
Pharmacovigilance surveillance, Coordination of adverse drug reaction reporting, Information dissemination on drug and vaccine safety, Training and educational projects
Content quality
good
Branding
consistent

Technology

Stack
HTML5, CSS3, Bootstrap 5.3.2, Bootstrap Icons 1.11.3
Frameworks
Bootstrap
Performance
moderate
Mobile
good
Accessibility
basic
SEO
basic

Security

Observed score
70/100
Good practices seen
  • HTTPS assumed (URL is https)
  • No forms detected that collect sensitive data

Analytics and tracking

Tracking level
minimal
Privacy practices
basic

Advertising

Transparency
poor

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Content is professionally presented and relevant to pharmacovigilance.
  3. No privacy or cookie consent mechanisms detected, which may be a compliance gap.
  4. No security policy or incident response information published.
  5. No forms detected that collect personal or sensitive data.
  6. WHOIS data supports legitimacy and consistency with business claims.
  7. No advertising or tracking technologies detected.
Technical notes

Notes

The website is built using standard HTML5 and CSS3 with Bootstrap 5.3.2 and Bootstrap Icons 1.11.3 loaded from jsDelivr CDN. No CMS or server-side technologies are evident from the HTML content. The site is mobile responsive with a clear navigation structure and consistent branding. Performance is moderate, likely due to external resource loading and basic optimization. Accessibility features are minimal but present. SEO is basic with proper meta charset and viewport tags but lacks advanced structured data or Open Graph metadata. Hosting provider details are not disclosed. No analytics or tracking scripts were detected.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with centrofarmacovigilanzabolzano.it. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review centrofarmacovigilanzabolzano.it.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.